MCR: An Interesting Fund, But Returns Haven’t Been Compelling (NYSE:MCR)
Diego Thomazini Written by Nick Ackerman, co-produced by Stanford Chemist. This article was originally published to members of the CEF/ETF Income Laboratory on August 21st, 2022. After covering MFS Special Value (MFV) recently, a reader […]
